APA引用形式

Ellis, N. A., Huo, D., Yildiz, O., Worrillow, L. J., Banerjee, M., Le Beau, M. M., . . . Onel, K. (2008). MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility. American Society of Hematology.

シカゴスタイル引用形

Ellis, Nathan A., Dezheng Huo, Ozlem Yildiz, Lisa J. Worrillow, Mekhala Banerjee, Michelle M. Le Beau, Richard A. Larson, James M. Allan, , Kenan Onel. MDM2 SNP309 and TP53 Arg72Pro Interact to Alter Therapy-related Acute Myeloid Leukemia Susceptibility. American Society of Hematology, 2008.

MLA引用形式

Ellis, Nathan A., et al. MDM2 SNP309 and TP53 Arg72Pro Interact to Alter Therapy-related Acute Myeloid Leukemia Susceptibility. American Society of Hematology, 2008.